Fusion event
HBV-LOC107984419 integration
Disease
Hepatocellular carcinoma (HCC)
Quality evaluation
Normal
Reference genome
AF090842.1;AB033554.1;AB014381.1;M32138.1;AB032431.1;AB036910.1;AB064310;AY090454.1
End
30875696/30854149 (Hg38)
Nearest miRNA
hsa-mir-210/Upstream/2376601; hsa-let-7a-2/Downstream/4087688;
Upstream sequence
GCctcaactctgagtacaacaaggaaaagtggaaatttatagtcaagaagcagagttgtggggggtagagaggctcagtgtgaaaactggtaagaggaaa
Downstream sequence
cattagggataagagggcgatagcagctaaagcaacctaatggggttcttgctgaaggcaggccagggtgacatcacctgagggatggtggagcatgaag
Target sequence
AGCTAAACTTTCTCCTTCTCAGTCTCCtgctagttattctacatttgatcctctccatctctacatgatttctctgccttttgctgccctgctgtaagttccagaagtctagcctcttcaagctacatcactcagacactcgggccctctggttttcagtgggatttagacaatggcagtaactggaagaaatcagagtatgggaggcaaaagagatcaggctatttatttctccatccctatacttttcctgct
Zhao, L. H., et al.Genomic and oncogenic preference of HBV integration in hepatocellular carcinoma. Nat Commun ,2016,7: 12992.